For instance, in many institutions such as ours, admission to a dedicated stroke unit is standard practice following administration of tissue plasminogen activator for acute ischemic stroke, whereas in other institutions lacking a stroke unit, the same clinical scenario requires admission to the NSICU for post-thrombolysis monitoring. The gene discussed is PLAT; the disease is Stroke.